Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
the only catalyst now is the UK MHRA meeting on 16 and 17 Sept. if the approval is given for the dementia drug, expect to get more news and actions on Friday or next week..if no approval, then cont to hover below rm2.
UIMB owe Bintai this money so nothing positive about it. it s just like you lend your friend rm10k in 2020 and now your friend willing to repay u rm2k in 2025/2026 and now another rm3k in 12 months installment after delaying it for 6 years since 2020. hence, it isn't a profit to Bintai but just a long outstanding receivables. your friend still owe you rm5k after this.
at this price now the boss has to pump own money already. his fortune and pledged shares dropped drastically and banks would chase him to top up his margin.
there would be a specific EAG review scheduled on Sept 16 and CHM scheduled on Sept 17. these two meetings mostly would discuss on the taurx drug.I said this because the specific EAG on Sept 16 is a subgroup for Neurology, Pain and Psychiatry which Taurx drug falls under this expertise.